Krebs Biochemicals & Industries Ltd.(IN:KREBSBIO)
₹58.55-0.45 (-0.76%)
IN:KREBSBIO
Krebs Biochemicals & Industries Ltd. financials statements
₹58.55
At close:-0.45 (-0.76%)
Want to see IN:KREBSBIO full AI Analyst Report?
Krebs Biochemicals & Industries Ltd. (KREBSBIO) Ratios
0 Followers
Krebs Biochemicals & Industries Ltd. Ratios
IN:KREBSBIO's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:KREBSBIO's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.09 | 0.10 | 0.28 | 0.33 | 0.45 |
| Quick Ratio | 0.03 | 0.04 | 0.12 | 0.08 | 0.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.03 | -0.06 | -0.04 | -0.07 | -0.14 |
| Operating Cash Flow Ratio | -0.08 | -0.08 | 0.04 | -0.50 | -0.22 |
| Short-Term Operating Cash Flow Coverage | -0.15 | -0.15 | 0.23 | -2.44 | -1.69 |
| Net Current Asset Value | ₹ -3.16B | ₹ -3.05B | ₹ -2.80B | ₹ -2.58B | ₹ -2.29B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.38 | 1.26 | 1.34 | 1.05 | 0.99 |
| Debt-to-Equity Ratio | -1.38 | -1.45 | -2.00 | -1.84 | -2.50 |
| Debt-to-Capital Ratio | 3.62 | 3.22 | 2.00 | 2.19 | 1.66 |
| Long-Term Debt-to-Capital Ratio | 205.65 | 10.74 | 2.85 | 2.35 | 2.30 |
| Financial Leverage Ratio | -1.00 | -1.16 | -1.49 | -1.76 | -2.53 |
| Debt Service Coverage Ratio | -0.05 | -0.25 | -0.56 | -1.16 | -2.11 |
| Interest Coverage Ratio | -1.68 | -3.67 | -3.31 | -7.38 | -7.33 |
| Debt to Market Cap | 2.62 | 1.45 | 1.39 | 1.51 | 0.46 |
| Interest Debt Per Share | 107.52 | 101.18 | 112.87 | 86.36 | 89.74 |
| Net Debt to EBITDA | -65.63 | -14.81 | -28.83 | -12.08 | -5.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.51% | 87.17% | -21.57% | 46.84% | -9.65% |
| EBIT Margin | -41.49% | -48.51% | -29.83% | -41.66% | -65.56% |
| EBITDA Margin | -14.43% | -33.06% | -16.41% | -29.08% | -55.01% |
| Operating Profit Margin | -50.03% | -50.15% | -30.72% | -42.08% | -66.15% |
| Pretax Profit Margin | -71.35% | -62.16% | -39.13% | -47.36% | -74.58% |
| Net Profit Margin | -71.35% | -62.20% | -39.13% | -47.36% | -74.58% |
| Continuous Operations Profit Margin | -71.35% | -62.20% | -39.13% | -47.36% | -74.58% |
| Net Income Per EBT | 100.00% | 100.06% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 142.61% | 123.97% | 127.36% | 112.55% | 112.74% |
| Return on Assets (ROA) | -10.37% | -15.94% | -11.07% | -14.11% | -23.46% |
| Return on Equity (ROE) | 10.40% | 18.42% | 16.55% | 24.83% | 59.30% |
| Return on Capital Employed (ROCE) | -23.66% | -33.15% | -13.31% | -17.43% | -35.34% |
| Return on Invested Capital (ROIC) | -10.65% | -18.65% | -12.24% | -16.13% | -32.40% |
| Return on Tangible Assets | -10.39% | -16.16% | -11.23% | -14.33% | -23.82% |
| Earnings Yield | -19.75% | -18.47% | -14.19% | -20.27% | -14.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5518.98 | 866.24 | 10.67 | 66.21 | 54.91 |
| Payables Turnover | 1.25 | 0.31 | 3.23 | 1.81 | 1.73 |
| Inventory Turnover | 3.02 | 0.92 | 5.98 | 2.24 | 2.53 |
| Fixed Asset Turnover | 0.17 | 0.30 | 0.34 | 0.35 | 0.41 |
| Asset Turnover | 0.15 | 0.26 | 0.28 | 0.30 | 0.31 |
| Working Capital Turnover Ratio | -0.24 | -0.63 | -1.30 | -1.38 | -1.72 |
| Cash Conversion Cycle | -170.85 | -795.91 | -17.74 | -33.00 | -60.49 |
| Days of Sales Outstanding | 0.07 | 0.42 | 34.22 | 5.51 | 6.65 |
| Days of Inventory Outstanding | 121.02 | 396.26 | 61.00 | 162.72 | 144.20 |
| Days of Payables Outstanding | 291.93 | 1192.59 | 112.96 | 201.24 | 211.34 |
| Operating Cycle | 121.09 | 396.68 | 95.22 | 168.24 | 150.85 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.18 | -3.66 | 1.10 | -11.46 | -7.99 |
| Free Cash Flow Per Share | -5.65 | -5.31 | -3.27 | -16.50 | -18.89 |
| Dividend Paid and CapEx Coverage Ratio | -2.84 | -2.21 | 0.25 | -2.27 | -0.73 |
| Capital Expenditure Coverage Ratio | -2.84 | -2.21 | 0.25 | -2.27 | -0.73 |
| Operating Cash Flow Coverage Ratio | -0.04 | -0.04 | 0.01 | -0.13 | -0.09 |
| Operating Cash Flow to Sales Ratio | -0.38 | -0.18 | 0.05 | -0.47 | -0.29 |
| Free Cash Flow Yield | -14.20% | -7.85% | -5.07% | -29.21% | -13.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.06 | -5.41 | -7.05 | -4.93 | -6.93 |
| Price-to-Sales (P/S) Ratio | 3.61 | 3.37 | 2.76 | 2.34 | 5.17 |
| Price-to-Book (P/B) Ratio | -0.53 | -1.00 | -1.17 | -1.22 | -4.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.04 | -12.74 | -19.73 | -3.42 | -7.57 |
| Price-to-Operating Cash Flow Ratio | -9.52 | -18.49 | 58.80 | -4.93 | -17.91 |
| Price-to-Earnings Growth (PEG) Ratio | 0.14 | -0.15 | 0.35 | 0.11 | -0.16 |
| Enterprise Value Multiple | -90.67 | -24.99 | -45.64 | -20.11 | -15.12 |
| Enterprise Value | 3.10B | 3.58B | 3.78B | 3.05B | 4.96B |
| EV to EBITDA | -90.67 | -24.99 | -45.64 | -20.11 | -15.12 |
| EV to Sales | 13.08 | 8.26 | 7.49 | 5.85 | 8.32 |
| EV to Free Cash Flow | -25.49 | -31.25 | -53.56 | -8.57 | -12.19 |
| EV to Operating Cash Flow | -34.47 | -45.36 | 159.67 | -12.34 | -28.84 |
| Tangible Book Value Per Share | -75.58 | -68.91 | -56.45 | -47.38 | -36.16 |
| Shareholders’ Equity Per Share | -75.45 | -67.84 | -55.29 | -46.13 | -34.83 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 11.00 | 20.09 | 23.39 | 24.18 | 27.69 |
| Net Income Per Share | -7.85 | -12.50 | -9.15 | -11.45 | -20.65 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.72 | 1.28 | 1.31 | 1.14 | 1.14 |
| Research & Development to Revenue | 0.00 | 0.04 | 0.00 | 0.00 | 0.03 |
| SG&A to Revenue | 0.78 | 0.38 | 0.01 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.53 | 0.29 | -0.12 | 1.00 | 0.39 |
Currency in INR

